Hillsdale Investment Management Inc. Immuno Precise Antibodies Ltd. Call Options Transaction History
Hillsdale Investment Management Inc.
- $1.77 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPA
# of Institutions
26Shares Held
3.93MCall Options Held
27.2KPut Options Held
0-
Ingalls & Snyder LLC New York, NY2.76MShares$1.35 Million0.03% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA703KShares$344,4700.0% of portfolio
-
Two Sigma Investments, LP New York, NY90.6KShares$44,3850.0% of portfolio
-
Virtu Financial LLC New York, NY57.8KShares$28,3450.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$20,1880.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $12.2M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...